Khalid Islam, Ph.D.

Khalid Islam, Ph.D.

Chair of the BoardatFennec Pharmaceuticals· In proxies 2023–2025

Khalid Islam, Ph.D. sits on 5 public boards.

Boards1

  • Fennec PharmaceuticalsChair · 11 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Fennec PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role +11%
  2. Gain TherapeuticsPublic company · 2 yr
    • Chair of the Board2024 – Present · 2 yrNo stock prices for these years
  3. Minoryx TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  4. ImmunomedicsPublic company
    • Director? – PresentNo stock prices for these years
  5. MolMed S.p.A.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?